Febrile neutropenia (FN) is a life-threatening complication of cancer chemotherapy and is considered a medical emergency. Patients with suspected febrile neutropenia should be assessed urgently and managed according to clincial presentation and risk assessment. Patients may not always present to the acute oncology team,and will access care via community or emergency teams ,so it is vital that all patient facing professionals are aware of the particular risks for this patients group, can commence urgent or emergency assessment and managment and can access expert advice and support easily.
National guidance has been issued by NICE and includes the following key recomendations:
-
hospitals should have a neutropenic sepsis policy, which includes management pathway
-
patient information and emergency contact instructions
-
risk assessment and identification of high and low risk patients
-
training and education for HCP in the recognition and management of patients with suspected neutropenic sepsis
Are you a health professional looking for immediate guidance?UKONS Acute Oncology Initial Management may help |
Helpful Links:
|
|
|
|
|
|
We are eager to develop the content of this page and would be pleased to accept contributions and suggestions, please contact us if you are able to help
Please note that you should always assume that the website group, society and authors /owners of any of these documents links or guidance make no representations or guarantees as to the accuracy, completeness or adequacy of any of the content and make no warranties express implied or otherwise and cannot be held responsible for any liability, loss or damage whatsoever caused by the use of the content. You should always act within the limits of your competence and seek senior advice or support where appropriate.